MED
Medifast, Inc. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1,
"returned": 1,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "57b36473-101f-4620-a187-db9abc05ac2e",
"title": "Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript",
"description": "Medifast, Inc. misses on earnings expectations. Reported EPS is $0.66 EPS, expectations were $0.78.",
"keywords": "",
"snippet": "Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript April 29, 2024\n\nMedifast, Inc. misses on earnings expectations. Reported EPS is $0.66 EPS, expectatio...",
"url": "https://www.insidermonkey.com/blog/medifast-inc-nysemed-q1-2024-earnings-call-transcript-1294964/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/10/19174527/MED-insidermonkey-1697751924709.jpg",
"language": "en",
"published_at": "2024-05-01T13:40:25.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "MED",
"name": "Medifast, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 148.46196,
"sentiment_score": 0.574945,
"highlights": [
{
"highlight": "<em>Medifast</em>, <em>Inc</em>. (<em>NYSE:MED</em>) Q1 2024 Earnings Call Transcript April 29, 2024\n\n<em>Medifast</em>, <em>Inc</em>. misses on earnings expectations. Reported EPS is $0.66 EPS, expectations were $0.78. MED isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).\n\nOperator: Greetings.",
"sentiment": 0.6077,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medifast</em> assumes no obligation to update any forward-looking statements that may be made in today’s release or call. And with that, I would like to turn the call over to <em>Medifast</em> Chairman and Chief Executive Officer Dan Chard.\n\nDan Chard: Thank you, Steve, and thank you all for joining us today. With me today is Jim Maloney, Medifast’s CFO.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "Medical innovation is empowering more people than ever before to achieve their weight loss goals and that presents a remarkable opportunity for <em>Medifast</em> as an organization.",
"sentiment": 0.7717,
"highlighted_in": "main_text"
},
{
"highlight": "A recent BCG study commissioned by <em>Medifast</em> determined that the GLP-1 support market, which includes products and services purchased by those on GLP-1 medications, excluding those medication costs, is roughly $13 billion today and could grow to $50 billion or more by the year 2030.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "A clinical study sponsored by <em>Medifast</em> showed that those on the optimal weight five-in-one plan with support of an OPTAVIA coach successfully lost 10 times more weight and 17 times more fat than those who try to lose weight on their own.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medifast</em> is committed to driving growth and enhancing brand visibility through a $30 million investment in company-led marketing efforts throughout 2024.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "This is a clear differentiator for <em>Medifast</em> versus others in our industry. The vast majority of our coaches started as OPTAVIA customers and therefore understand the mindset and needs of someone looking to better their overall health.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "With a comprehensive holistic approach that brings together customers, coaches, and clinicians, <em>Medifast</em> is uniquely positioned to provide the nutritional and healthy lifestyle support that GLP-1 users need to achieve their lifelong transformation that they’re seeking.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "We believe that <em>Medifast</em> has the financial strength and strategic flexibility to invest in our ongoing operational and marketing effectiveness, and the scientific and medical heritage that provides us with the credibility to play in this rapidly developing space.",
"sentiment": 0.7906,
"highlighted_in": "main_text"
},
{
"highlight": "Q&A Session\n\nFollow <em>Medifast</em> <em>Inc</em> (<em>NYSE:MED</em>) Follow <em>Medifast</em> <em>Inc</em> (<em>NYSE:MED</em>) or Subscribe with Google We may use your email to send marketing emails about our services. Click here to read our privacy policy.\n\nOperator: Thank you. At this time, we will be conducting a question-and-answer session.",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medifast</em>, <em>Inc</em>. (<em>NYSE:MED</em>) Q1 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "MED",
"total_documents": 1,
"sentiment_avg": 0.5749449729919434
}
]
}
Other details
Exchange
- New York Stock Exchange
- equity
- Consumer Cyclical
- us